OncoSec Medical to Wrap up 2013 With Multiple Possible Catalysts
Imminent Catalyst for Idera Pharmacueticals Should Garner Positive Investor Interest
The Battle of IL-12 Administration For Cancer Treatment: Is It Really A Battle?
Investments in "Medical Science Fiction"
Multiple Antigen Targeting Could Mean Multiple Marketing for These Immunotherapy Drugs
Stem Cell Biotechs: A Frontrunner Emerges?
ImmunoCellular's Intellectual Property Steadily Increases
Verastem IPO Launch Captures Investors Attention